Terms: = Gastric cancer AND EML4, ENSG00000143924, 27436
7 results:
1. [Multiple pulmonary nodules with interstitial changes].
Yang SQ; Hao M; Gao YL; Zhang YH; Yang MF; Jin ML; Fang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):783-789. PubMed ID: 35927049
[TBL] [Abstract] [Full Text] [Related]
2. gastric mesenchymal tumor with smooth muscle differentiation and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (eml4-ALK) fusion.
Akimoto E; Tokunaga M; Sato R; Yoshida A; Naito Y; Yamashita R; Kinoshita T; Kuwata T
Pathol Int; 2021 Oct; 71(10):707-711. PubMed ID: 34432920
[TBL] [Abstract] [Full Text] [Related]
3. An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
Duan X; Zhao X; Wang S
Ann Palliat Med; 2021 May; 10(5):5797-5807. PubMed ID: 32819126
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of Synchronous Double cancer of the Lung and Stomach That Responded to Cisplatin and S-1 Combination Chemotherapy].
Sugiyama T; Kasai T; Nakamura Y; Kamiyama Y; Mori K
Gan To Kagaku Ryoho; 2017 Jan; 44(1):67-69. PubMed ID: 28174383
[TBL] [Abstract] [Full Text] [Related]
5. Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract cancer: Implication for Targeted Therapy in Chinese Population.
Ying J; Lin C; Wu J; Guo L; Qiu T; Ling Y; Shan L; Zhou H; Zhao D; Wang J; Liang J; Zhao J; Jiao Y; Lu N; Zhao H
PLoS One; 2015; 10(12):e0144731. PubMed ID: 26678488
[TBL] [Abstract] [Full Text] [Related]
6. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.
Lee J; Kim HC; Hong JY; Wang K; Kim SY; Jang J; Kim ST; Park JO; Lim HY; Kang WK; Park YS; Lee J; Lee WY; Park YA; Huh JW; Yun SH; Do IG; Kim SH; Balasubramanian S; Stephens PJ; Ross JS; Li GG; Hornby Z; Ali SM; Miller VA; Kim KM; Ou SH
Oncotarget; 2015 Sep; 6(27):24320-32. PubMed ID: 26172300
[TBL] [Abstract] [Full Text] [Related]
7. A novel lead compound CM-118: antitumor activity and new insight into the molecular mechanism and combination therapy strategy in c-Met- and ALK-dependent cancers.
Meng L; Shu M; Chen Y; Yang D; He Q; Zhao H; Feng Z; Liang C; Yu K
Cancer Biol Ther; 2014 Jun; 15(6):721-34. PubMed ID: 24618813
[TBL] [Abstract] [Full Text] [Related]
